ASK REDCHAT ANYTHING ABOUT TRAWS PHARMA, INC.
Traws Pharma, Inc. (NASDAQ: TRAW)
Listen to this Section
$1.45
+0.0310
(
+2.18% )
174.9K
Sign up for The Small Stocks Big Money Newsletter and receive free small-cap news and insights.
Clinical Trial Pipeline Stages
| Drug Name |
Stage |
| Rigosertib + PembrolizumabDetailsMelanoma, Skin cancer, Cancer |
Phase 2 |
| Rigosertib (RAS inhibitor)DetailsCutaneous squamous cell carcinoma, Cancer, Solid tumor/s |
Phase 2 |
| TRX100 (tivoxavir marboxil)DetailsInfluenza, Viral infection |
Phase 2 |
| Ratutrelvir (TRX01)DetailsCOVID-19 |
Phase 2a |
| Rigosertib + NivolumabDetailsCancer, Non-small cell lung carcinoma |
Phase 1/2 |
| Narazaciclib (ON 123300) (CDK4/6 & ARK5 inhibitor)DetailsSolid tumor/s, Cancer, ER+/HER2- breast cancer, Breast cancer, Metastatic breast cancer |
Phase 1/2 |
| Narazaciclib + letrozoleDetailsCancer, Solid tumor/s, Endometrial cancer |
Phase 1/2 |
| RigosertibDetailsMyelodysplastic syndrome |
Failed |
Market Data
|
| Open |
$1.45 |
| Previous Close |
$1.42 |
| Volume |
174.9K |
| Market Cap |
$21.51M |
| Day Range |
$1.39 - $1.47 |
| 52 Week Range |
$1.00 - $3.27 |
| Shares Outstanding |
15.15M |
| Change % |
+2.18% |
| Net Change |
▲ 0.0310 |
| Insider Ownership |
-0.02% |
| Exchange |
NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Year | 2013 |
| Country | United States |
Insider Ownership Transactions
Total Amount Purchased:
-1,201,464.00
| Date |
Type |
Amount Purchased |
Purchaser |
| 2024-06-20 |
Sale |
-5500.00 |
Guerin Mark Patrick |
| 2024-04-03 |
Sale |
-66687.00 |
Dukes Iain D. |
| 2024-04-03 |
Sale |
-97500.00 |
Redfield Robert |
| 2024-04-03 |
Sale |
-97500.00 |
Pauza Charles David |
| 2024-04-03 |
Sale |
-200000.00 |
CAUTREELS WERNER |
| 2024-04-03 |
Sale |
-66687.00 |
Savchuk Nikolay |
| 2024-03-15 |
Sale |
-23111.00 |
Fruchtman Steven M |
| 2024-03-15 |
Sale |
-8666.00 |
Guerin Mark Patrick |
| 2024-02-09 |
Sale |
-21320.00 |
Fruchtman Steven M |
| 2024-02-09 |
Sale |
-6900.00 |
Guerin Mark Patrick |
SEC Filings
| Form Type |
Description |
Pages |
Date |
| 8-k |
8K-related |
60 |
Nov 13, 2025 |
| 10-q |
Quarterly Reports |
77 |
Nov 13, 2025 |
| 8-k |
8K-related |
12 |
Oct 17, 2025 |
| 4 |
Insider transactions |
1 |
Oct 15, 2025 |
| 4 |
Insider transactions |
1 |
Oct 15, 2025 |
| 4 |
Insider transactions |
1 |
Oct 15, 2025 |
| 4 |
Insider transactions |
1 |
Oct 15, 2025 |
| 4 |
Insider transactions |
1 |
Oct 15, 2025 |
| 4 |
Insider transactions |
1 |
Oct 15, 2025 |
| 4 |
Insider transactions |
1 |
Oct 15, 2025 |